Moderna stock tumbles as 2025 revenue guidance falls $1 billion short
Moderna stock dropped 18% after the company slashed its 2025 revenue forecast by $1 billion, citing declining COVID vaccine demand, market competition, and other financial...
Tag : Covid Vaccine
Pfizer reports significant loss amid Paxlovid and vaccine challenges
Pfizer, the pharmaceutical giant, revealed a significant quarterly loss for the third quarter, largely attributed to charges associated with the struggles of its Covid antiviral...